Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FABIAN, Carol J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 30

  • Page / 2
Export

Selection :

  • and

Chemoprevention of breast cancer: Implications for postmenopausal womenFABIAN, Carol J; KIMLER, Bruce F.Drugs & aging. 2002, Vol 19, Num 1, pp 43-78, issn 1170-229XArticle

Mammographic density : Use in risk assessment and as a biomarker in prevention trials : Biomarkers as indicators of cancer risk reduction following dietary manipulationFABIAN, Carol J; KIMLER, Bruce F.The Journal of nutrition. 2006, Vol 136, Num 10, issn 0022-3166, 2705S-2708SArticle

Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007SCHWARTZ, Gordon F; HUGHES, Kevin S; LYNCH, Henry T et al.Cancer. 2008, Vol 113, Num 10, pp 2627-2637, issn 0008-543X, 11 p.Article

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPROEUHUS, David M; SMITH, Kristin C; ESSERMAN, Laura et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 11, pp 844-851, issn 0027-8874, 8 p.Article

A Prospective Model of Care for Breast Cancer Rehabilitation: Bone Health and ArthralgiasWINTERS-STONE, Kerri M; SCHWARTZ, Anna L; HAYES, Sandra C et al.Cancer. 2012, Vol 118, Num 8, pp 2288-2299, issn 0008-543X, 12 p., SUPArticle

Exemestane for Breast-Cancer Prevention in Postmenopausal WomenGOSS, Paul E; INGLE, James N; WINQUIST, Eric et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2381-2391, issn 0028-4793, 11 p.Article

Hypermethylation of the Breast Cancer-Associated Gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer riskBEAN, Gregory R; IBARRA DRENDALL, Catherine; FABIAN, Carol J et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 1, pp 50-56, issn 1055-9965, 7 p.Article

Use of biomarkers for breast cancer risk assessment and preventionFABIAN, Carol J; KIMLER, Bruce F.Journal of steroid biochemistry and molecular biology. 2007, Vol 106, Num 1-5, pp 31-39, issn 0960-0760, 9 p.Conference Paper

Outcomes of a weight loss intervention among rural breast cancer survivorsBEFORT, Christie A; KLEMP, Jennifer R; AUSTIN, Heather L et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 631-639, issn 0167-6806, 9 p.Article

Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index scoreSHARMA, Priyanka; KIMLER, Bruce F; WARNER, Chezna et al.Breast cancer research and treatment. 2006, Vol 100, Num 1, pp 71-76, issn 0167-6806, 6 p.Article

Breast cancer chemoprevention Phase I evaluation of biomarker modulation by Arzoxifene, a third generation selective estrogen receptor modulatorFABIAN, Carol J; KIMLER, Bruce F; GANZ, Patricia A et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5403-5417, issn 1078-0432, 15 p.Article

Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimensSHARMA, Priyanka; KLEMP, Jennifer R; SIMONSEN, Marie et al.Breast cancer research and treatment. 2004, Vol 87, Num 1, pp 59-64, issn 0167-6806, 6 p.Article

Factors associated with success of the extreme drug resistance assay in primary breast cancer specimensELLIS, Robert J; FABIAN, Carol J; MCGINNESS, Marilee et al.Breast cancer research and treatment. 2002, Vol 71, Num 2, pp 95-102, issn 0167-6806Article

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal womenFABIAN, Carol J; KIMLER, Bruce F; ZALLES, Carola M et al.Breast cancer research and treatment. 2013, Vol 142, Num 1, pp 119-132, issn 0167-6806, 14 p.Article

Characterization of a preclinical model of simultaneous breast and ovarian cancer progressionTING, Alison Y; KIMLER, Bruce F; FABIAN, Carol J et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 1, pp 130-135, issn 0143-3334, 6 p.Article

Grading invasive ductal carcinoma of the breast : advantages of using automated proliferation index instead of mitotic countTAWFIK, Ossama; KIMLER, Bruce F; CONNOR, Carol et al.Virchows Archiv. 2007, Vol 450, Num 6, pp 627-636, issn 0945-6317, 10 p.Article

Retinoic acid receptor-β2 promoter methylation in random periareolar fine needle aspirationBEAN, Gregory R; SCOTT, Victoria; FABIAN, Carol J et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 4, pp 790-798, issn 1055-9965, 9 p.Article

Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of ExpertsNELSON, David E; FAUPEL-BADGER, Jessica; FABIAN, Carol J et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 4, pp 679-683, issn 1055-9965, 5 p.Article

Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six monthsFRANK, Denise H; KIMLER, Bruce F; FABIAN, Carol J et al.Breast cancer research and treatment. 2009, Vol 115, Num 3, pp 661-668, issn 0167-6806, 8 p.Article

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneVAHDAT, Linda T; PRUITT, Brian; SMITH, John et al.Journal of clinical oncology. 2009, Vol 27, Num 18, pp 2954-2961, issn 0732-183X, 8 p.Article

Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspirationKHAN, Qamar J; KIMLER, Bruce F; CLARK, Julie et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 4, pp 786-789, issn 1055-9965, 4 p.Article

Selective estrogen-receptor modulators for primary prevention of breast cancerFABIAN, Carol J; KIMLER, Bruce F.Journal of clinical oncology. 2005, Vol 23, Num 8, pp 1644-1655, issn 0732-183X, 12 p.Article

A Phase II breast cancer chemoprevention trial of oral α-difluoromethylornithine: Breast tissue, imaging, and serum and urine biomarkersFABIAN, Carol J; KIMLER, Bruce F; BOYD, Norman F et al.Clinical cancer research. 2002, Vol 8, Num 10, pp 3105-3117, issn 1078-0432, 13 p.Article

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast CancerMAUNSELL, Elizabeth; GOSS, Paul E; HENDRIX, Susan et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1427-1436, issn 0732-183X, 10 p.Article

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifenePOWLES, Trevor J; DIEM, Susan J; CUMMINGS, Steven R et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 299-306, issn 0167-6806, 8 p.Article

  • Page / 2